DA
AMGN icon

Dillon & Associates’s Amgen AMGN Stock Holding History

Dillon & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$899K Sell
2,483
-25
-1% -$8.56K 0.11% 54
2026
Q1 		$883K Buy
2,508
+25
+1% +$8.91K 0.12% 51
2025
Q4 		$812K Hold
2,483
– – 0.1% 53
2025
Q3 		$700K Hold
2,483
– – 0.09% 55
2025
Q2 		$693K Buy
2,483
+2
+0.1% +$567 0.09% 56
2025
Q1 		$774K Sell
2,481
-180
-7% -$53.2K 0.12% 57
2024
Q4 		$695K Hold
2,661
– – 0.1% 59
2024
Q3 		$857K Buy
2,661
+45
+2% +$14.7K 0.12% 56
2024
Q2 		$816K Hold
2,616
– – 0.12% 59
2024
Q1 		$743K Hold
2,616
– – 0.12% 60
2023
Q4 		$753K Sell
2,616
-3
-0.1% -$817 0.14% 58
2023
Q3 		$705K Sell
2,619
-5
-0.2% -$1.25K 0.14% 57
2023
Q2 		$583K Hold
2,624
– – 0.11% 60
2023
Q1 		$635K Sell
2,624
-150
-5% -$36.8K 0.13% 58
2022
Q4 		$730K Hold
2,774
– – 0.16% 57
2022
Q3 		$624K Hold
2,774
– – 0.14% 57
2022
Q2 		$674K Sell
2,774
-50
-2% -$12.3K 0.15% 54
2022
Q1 		$683K Sell
2,824
-100
-3% -$23K 0.13% 52
2021
Q4 		$658K Buy
2,924
+120
+4% +$25.3K 0.11% 51
2021
Q3 		$597K Sell
2,804
-30
-1% -$6.91K 0.11% 51
2021
Q2 		$691K Hold
2,834
– – 0.14% 50
2021
Q1 		$706K Sell
2,834
-50
-2% -$11.9K 0.15% 50
2020
Q4 		$663K Sell
2,884
-100
-3% -$23.1K 0.14% 50
2020
Q3 		$758K Buy
2,984
+45
+2% +$11.1K 0.18% 49
2020
Q2 		$694K Sell
2,939
-50
-2% -$11.4K 0.19% 50
2020
Q1 		$607K Hold
2,989
– – 0.2% 49
2019
Q4 		$720K Sell
2,989
-150
-5% -$33.1K 0.2% 48
2019
Q3 		$609K Hold
3,139
– – 0.19% 48
2019
Q2 		$578K Hold
3,139
– – 0.18% 51
2019
Q1 		$596K Hold
3,139
– – 0.19% 49
2018
Q4 		$612K Hold
3,139
– – 0.23% 48
2018
Q3 		$650K Hold
3,139
– – 0.22% 48
2018
Q2 		$581K Sell
3,139
-100
-3% -$17.7K 0.21% 48
2018
Q1 		$551K Sell
3,239
-300
-8% -$55.1K 0.21% 50
2017
Q4 		$616K Hold
3,539
– – 0.23% 49
2017
Q3 		$658K Sell
3,539
-200
-5% -$35.4K 0.26% 48
2017
Q2 		$643K Hold
3,739
– – 0.27% 49
2017
Q1 		$613K Hold
3,739
– – 0.26% 50
2016
Q4 		$546K Hold
3,739
– – 0.25% 50
2016
Q3 		$624K Hold
3,739
– – 0.29% 51
2016
Q2 		$568K Hold
3,739
– – 0.26% 51
2016
Q1 		$561K Hold
3,739
– – 0.26% 50
2015
Q4 		$606K Hold
3,739
– – 0.29% 47
2015
Q3 		$516K Buy
3,739
+164
+5% +$25.9K 0.26% 49
2015
Q2 		$551K Hold
3,575
– – 0.27% 48
2015
Q1 		$572K Sell
3,575
-500
-12% -$78.7K 0.27% 48
2014
Q4 		$648K Hold
4,075
– – 0.31% 47
2014
Q3 		$571K Hold
4,075
– – 0.29% 49
2014
Q2 		$480K Buy
4,075
+75
+2% +$8.68K 0.25% 50
2014
Q1 		$492K Buy
4,000
+150
+4% +$18.2K 0.26% 52
2013
Q4 		$439K Hold
3,850
– – 0.24% 51
2013
Q3 		$454K Hold
3,850
– – 0.25% 51
2013
Q2 		$381K Buy
+3,850
New +$400K 0.24% 52

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Dillon & Associates's AMGN Position: Q2 2026 in Review

Dillon & Associates reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $8.56K and leaving 2,483 shares worth $899K. The position accounts for 0.11% of the portfolio, ranked #54.

Dillon & Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Dillon & Associates held 2,483 shares of Amgen worth $899K as of Q2 2026.
  • Dillon & Associates sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
  • Amgen made up 0.11% of Dillon & Associates's portfolio in Q2 2026, its #54 holding.
  • Dillon & Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Dillon & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.